At the forefront of therapies for rare and orphan diseasesTM
HOME OUR LOCATIONS CONTACT US         
Share
about us| programs| science & technology | patient advocacy | clinical studies | investors | collaborations | news & events
 
Amicus Therapeutics is a biotechnology company at the forefront of advanced therapies to treat a range of devastating rare and orphan diseases.
More...
NEWS
02/03/2016 Amicus Therapeutics to Present at the Leerink Partners 5th Annual Global Healthcare Conference
01/11/2016 Amicus Therapeutics Provides Full-Year 2016 Strategic Outlook and Financial Guidance
01/04/2016 Amicus Therapeutics to Present at the 34th Annual J.P. Morgan Healthcare Conference and 3rd Annual Dermatology Summit
More...
Amicus Therapeutics CEO: Driving science to a cure
John Crowley, Amicus Therapeutics chairman and CEO, discusses its Fabry pill development and next generation therapy for Pompe disease, with CNBC's Jim Cramer.



Click Here to Read the Article

Copyright © 2016 Amicus Therapeutics, Inc. All rights reserved.   Terms of Use | Privacy Policy